ELIXIR
A Study to EvaLuate the EffIcacy and Safety of XyloCore, a Glucose SparIng ExpeRimental Solution, for Peritoneal Dialysis
Randomized, controlled, parallel groups, open label, blinded end-point assessment, multi centre study, comparing the effects of a low glucose PD solution, XyloCore, to glucose-only PD solutions only regimen, in patients with End-Stage Renal Disease (ESRD) receiving Continuous Ambulatory Peritoneal Dialysis (CAPD), over a 6 month study period.
Researcher: